The role of albumin replacement in the critically ill veterinary patient

Journal of Veterinary Emergency and Critical Care

Volumn 12, Issue 2, 2002, Pages 113-124

  Mazzaferro, Elisa M ^a   Rudloff, Elke ^b   Kirby, Rebecca ^b  

^a Veterinary Dentistry and Oral Surgery   (United States)

^b Animal Emergency Center   (United States)

Author keywords

Colloid therapy; Critical illness; Oncotic pressure; Plasma

Indexed keywords

EID: 12744275562     PISSN: 14793261     EISSN: 14764431     Source Type: Journal    
DOI: 10.1046/j.1435-6935.2002.00025.x     Document Type: Review

References (77)

1. Weil MH, Henning RJ, Puri VK. Colloid oncotic pressure: clinical significance. Crit Care Med 1979; 7(3):113–116.pmid/436426
2. D'Angio RG. Is there a role for albumin in nutrition support? Ann Pharmacother 1994; 28(4):478–482.pmid/8038474
3. Ford EG, Jennings LM, Andrassy RJ. Serum albumin (oncotic pressure) correlates with enteral feeding intolerance in the pediatric surgical patient. J Pediatr Surg 1987; 22(7): 597–599.pmid/3112363
4. Powanda MC, Moyer ED. Plasma proteins and wound healing. Surg Gynecol Obstet 1981; 153(3):749–753.pmid/7027503
5. Foley EF, Borlase BC, Dzik WH, et al. Albumin supplementation in the critically ill. Arch Surg 1990; 125(6): 739–742.pmid/2111981
6. Harvey HJ. Complications of small intestinal biopsy in hypoalbuminemic dogs. Vet Surg 1990; 19(4):289–292.pmid/2102666
7. Jorgensen KA, Stoffersen E. Heparin like activity of albumin. Thromb Res 1979; 16: 569–574.pmid/516011
8. Jorgensen KA, Stoffersen E. On the inhibitory effects of albumin on platelet aggregation. Thromb Res 1980; 17(1–2):13–18.pmid/6990546
9. Jackson CA, Greaves M, Patterson AD, et al. Relationship between platelet aggregation, thromboxane synthesis and albumin concentration in nephrotic syndrome. Br J Haematol 1982; 52(1):69–77.pmid/6810912
10. Green RA, Russo EA, Greene RT, et al. Hypoalbuminemia-related platelet hypersensitivity in two dogs with nephrotic syndrome. J Am Vet Med Assoc 1985; 186(5):485–488.pmid/2982777
11. Rao AK, Koike K, Day HJ, et al. Bleeding disorder associated with albumin-dependent partial deficiency in platelet thromboxane production. Am J Clin Path 1985; 83(6): 687–696.pmid/3923822
12. Sloand EM, Bern MM, Kaldany A. Effect on platelet function of hypoalbuminemia in peritoneal dialysis. Thromb Res 1986; 44(4):419–425.pmid/3798407
13. Iseki K, Kawazoe N, Fukiyama K. Serum albumin is a strong predictor of death in chronic dialysis patients. Kidney Int 1993; 44(1):115–119.pmid/8355451
14. McEllistrum MC, Collins JC, Powers JS. Admission serum albumin level as a predictor of outcome among geriatric patients. South Med J 1993; 86(12):1360–1361.pmid/8093126
15. Law MR, Morris JK, Wald NJ, et al. Serum albumin and mortality in the BUPA study. Int J Epidemiol 1994; 23(1):38–41.pmid/8194921
16. Moore LE, Garvey MS. The effects of hetastarch on serum colloid oncotic pressure in hypoalbuminemic dogs. J Vet Intern Med 1996; 10(5):300–303.pmid/8884715
17. Drobatz KJ, Macintire DK. Heat-induced illness in dogs: 53 cases (1976–1993). J Am Vet Med Assoc 1996; 209(11): 1894–1899.pmid/8944805
18. Logan JC, Callan MB, Drew K, et al. Clinical indications for use of fresh frozen plasma in dogs: 74 dogs (October through December 1999). J Am Vet Med Assoc 2001; 218(9):1449–1455.pmid/11345309
19. Ikenoue N, Saitsu Y, Shimoda M, et al. Disease-induced alterations in plasma drug-binding proteins and their influence on drug binding percentages in dogs. Vet Q 2000; 22(1):43–49.pmid/10682387
20. Brown J. Structural origins of mammalian albumin. Fed Proc 1976; 35: 2141–2144.pmid/947793
21. Doweiko JP, Nompleggi DJ. Role of albumin in human physiology and pathophysiology. J Parent Ent Nutr 1991; 15(2):207–211.
22. Schwartzkopff W, Schwartzkopff B, Wurm W, et al. Physiological aspects of albumin in the treatment of chronic and acute blood loss. Symposium of the Standardization of Albumin, Plasma Substitutes and Plasmaphoresis. Dev Biol Standardization 1981; 48: 7–30.
23. Rothschild MA, Oratz M, Schreiber SS. Albumin synthesis (first of two parts). N Eng J Med 1972; 286(14):748–757.
24. Rothschild MA, Oratz M, Schreiber SS. Albumin synthesis (second of two parts). N Eng J Med 1972; 286(15):816–821.
25. Tullis JL. Albumin: background and use. J Am Med Assoc 1977; 237(4):355–359.
26. Rothschild MA, Oratz M, Schreiber SS. Serum albumin. Hepatology 1988; 8(2):385–401.pmid/3281888
27. Guyton AC, Hall JE. The microcirculation and the lymphatic system. In: Textbook of Medical Physiology. 9th edn. Philadelphia: W.B. Saunders Co 1996, p. 170.
28. Griffel MI, Kaufman BS. Pharmacology of colloids and crystalloids. Crit Care Clin 1992; 8(2):235–253.pmid/1568139
29. Beathard GA. Albumin abnormalities. In: Ritzman SE, Daniels JC, eds. Serum Protein Abnormalities: Diagnostic and Clinical Aspects. Little and Brown; 1975, pp. 173–210.
30. Rothschild MA, Oratz M, Schreiber SS. Albumin metabolism. Gastroenterology 1973; 64(2):324–337.pmid/4568596
31. Haupt MT, Rackow EC. Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin and saline. Crit Care Med 1982; 10(3):159–162.pmid/6174274
32. Dixon FJ, Maurer PH, Deichmiller MP. Half-lives of homologous serum albumin in several species. Proc Soc Exp Biol Medical 1953; 83: 287–288.
33. Kaminski MV, Haase TJ. Albumin and colloid osmotic pressure: Implications for fluid resuscitation. Crit Care Clin 1992; 8(2):311–321.pmid/1568142
34. Kramer GC, Harms BA, Bodai BI, et al. Mechanisms for redistribution of plasma protein following acute protein depletion. Am J Physiol 1982; 243(5):H803–H809.pmid/7137372
35. Golub R, Sorrento JJ, Cantu E, et al. Efficacy of albumin supplementation in the surgical intensive care unit: a prospective, randomized trial. Crit Care Med 1994; 22(4):613–619.pmid/8143470
36. Thomas LA, Brown SA. Relationship between colloid osmotic pressure and plasma protein concentration in cattle, horses, dogs and cats. Am J Vet Res 1992; 53(12): 2241–2244.pmid/1282310
37. Rackow EC, Falk JL, Fein A, et al. Fluid resuscitation in circulatory shock: a comparison of cardiorespiratory effects of albumin, hetastarch and saline solutions in patients with hypovolemic and septic shock. Crit Care Med 1983; 11(11):839–850.pmid/6194934
38. Lucas CE, Ledgerwood AM, Higgins RF, et al. Impaired pulmonary function after albumin resuscitation from shock. J Trauma 1980; 20(6):446–451.pmid/7373672
39. Doweiko JP, Nompleggi DJ. Use of albumin as a Volume expander. J Parent Ent Nutr 1991; 15(4):484–487.
40. Starling EH. On the absorption of fluids from the connective tissue spaces. J Physiol 1894; 140: 312–326.
41. Emerson TE. Unique features of albumin: a brief review. Crit Care Med 1989; 17(7):690–694.pmid/2661149
42. Tullis JL. Albumin: guidelines for clinical use. J Am Med Assoc 1977; 237(5):460–463.
43. Center SA. Pathophysiology, laboratory diagnosis and diseases of the liver. In: Ettinger SJ, Feldman EC, eds. Textbook of Veterinary Internal Medicine. Philadelphia: W.B. Saunders Co 1995, pp. 1261–1312.
44. Lewis RT. Albumin: role and discriminate use in surgery. Can J Surg 1980; 23(4):322–328.pmid/6998548
45. Vallner JJ. Binding of drugs by albumin and plasma protein. J Pharm Sci 1977; 66(4):447–465.pmid/323460
46. Koch-Weser J, Sellers EM. Binding of drugs to serum albumin. N Eng J Med 1976; 294(10):526–531.
47. Doweiko JP, Nompleggi DJ. Interactions of albumin and medications. J Parent Ent Nutr 1991; 15(2):212–214.
48. Doweiko JP, Bistrian BR. The effects of glycosylated albumin on platelet aggregation. J Parent Ent Nutr 1994; 18(6):516–520.
49. Doweiko JP, Nompleggi DJ. The role of albumin in human physiology and pathophysiology: Part III. Albumin and disease states. J Parent Ent Nutr 1991; 15(4):476–483.
50. Holt ME, Ryall MET, Campbell AK. Albumin inhibits human polymorphonuclear leucocyte luminol-dependent chemiluminescence: evidence for oxygen radical scavenging. Br J Exp Path 1948; 65: 231–241.
51. Emerson TE, Redens TB, Lindsey CL. Human serum albumin pretreatment attenuates lung dysfunction in the endotoxemic sheep ARDS model. Fed Am Soc Exp Biol J 1988; 2: A997.
52. Mecray PM, Barden RP, Ravdin IS. Nutritional edema: its effects on the gastric emptying time before and after gastric operations. Surgery 1936; 1: 53–64.
53. Barden RP, Thompson WD, Ravdin IS, et al. The influence of serum protein on the motility of the small intestine. Surg Gynecol Obstet 1938; 66: 819–821.
54. Fleck A, Hawker F, Wallace PI, et al. Increased vascular permeability: a major cause of hypoalbuminemia in disease and injury. Lancet 1985; 1(8432):781–783.pmid/2858667
55. Schierhout G, Roberts I. Fluid resuscitation with colloids and crystalloids: a systematic review of randomized controlled trials. Br J Med 1998; 316(7136):961–964.
56. Bunn F, Lefebvre C. Li Wan Po A. Human albumin solutions for resuscitation and volume expansion in critically ill patients. The Albumin Reviewers. Cochrane Database of Systematic Reviews (computer file) 2000; 2:CD001208.
57. McLelland B. Albumin: don't confuse us with the facts. Br Med J 1998; 317: 829–830.
58. Street AM, Keller AJ. Adverse effects of albumin – uncertain times. Med J Aust 1999; 170(8):398–399.pmid/10327961
59. Allison SP, Lobo DN. Debate: Albumin administration should not be avoided. Crit Care (London) 2000; 4(3): 147–150.
60. Wilkes MM, Navickis RJ. Patient survival after human albumin administration. Ann Intern Med 2001; 135(3): 149–164.pmid/11487482
61. Choi PTL, Yip G, Quinonez LG, et al. Crystalloids versus colloids in fluid resuscitation. a systematic review. Crit Care Med 1999; 27(1):200–210.pmid/9934917
62. Webb AR. The appropriate role of colloids in managing fluid imbalance: a critical review of recent meta-analytic findings. Crit Care (London) 2000; 4: S26–S32.
63. Smiley LE, Garvey MS. The use of hetastarch as adjunct therapy in 53 dogs with hypoalbuminemia: a phase two clinical trial. J Vet Intern Med 1994; 8(3):195–202.pmid/7520494
64. Zilg H, Schneider H, Seiler FR. Molecular aspects of albumin functions: indications for its use in plasma substitutions. Symposium for the Standardization of Albumin, Plasma Substitutes and Plasmapharesis. Dev Biol Standardization 1981; 48: 31–42.
65. Llop JM, Munoz C, Badia MB, et al. Serum albumin as indicator of clinical evolution in patients on parenteral nutrition: multivariate study. Clin Nutr 2001; 20(1):77–81.pmid/11161547
66. Boldt J, Heesen M, Muller M, et al. The effects of albumin versus hydroxyethyl starch solution on cardiorespiratory and circulatory variables in critically ill patients. Anesth Analg 1996; 83(2):254–261.pmid/8694302
67. Kirby R, Rudloff E. The critical need for colloids: maintaining fluid balance. Comp Cont Ed Pract Vet 1997; 19(6): 705–717.
68. Mbaba Mena J, DeBacker D, Vincent JL. Effects of a hydroxyethylstarch solution in plasma colloid osmotic pressure in acutely ill patients. Acta Anaesthesiol Belgica 2001; 51: 39–42.
69. Cotter S. Clinical Transfusion Medicine. Adv Vet Sci Comp Medical 1991; 36: 187–223.
70. Reinhardt GF, Wilkins DB, Mysocofski JE, et al. Incidence and mortality of hypoalbuminemic patients in hospitalized veterans. J Parent Ent Nutr 1980; 4(4):357–359.
71. Rudloff E, Kirby R. Hypovolemic shock and resuscitation. Vet Clin North Am Small Anim Pract 1994; 24(6): 1015–1039.pmid/7879352
72. Kristensen AT. Administration of blood products to animals. In: Bistner SI, Ford RB, eds. Kirk and Bistner's Handbook of Veterinary Procedures and Emergency Treatment. Philadelphia: W.B. Saunders Co 1995, pp. 561–573.
73. Wolfsheimer KJ. Fluid therapy in the critically ill patient. Vet Clin North Am Small Anim Pract 1989; 19(2):361–378.pmid/2494783
74. Smiley LE. The use of hetastarch for plasma expansion. Prob Vet Med 1992; 4(4):652–667.
75. Chan DL, Freeman LM, Rozanski EA, et al. Colloid osmotic pressure of parenteral nutrition components and intravenous fluids. J Vet Emerg Crit Care 2001; 11(4):269–273.
76. Dahlinger J, Marks SL, Hirsh DC. Prevalence and identity of translocating bacteria in healthy dogs. J Vet Intern Med 1997; 11(6):319–321.pmid/9470154
77. Weeren FR, Muir WW. Clinical aspects of septic shock and comprehensive approaches to treatment in dogs. J Am Vet Med Assoc 1992; 200(12):1859–1869.pmid/1639691